AI Turns Stem Cells Into Predictive, Scalable Therapies

AI-native platforms are transforming stem-cell research into predictive engineering, accelerating the design, testing, and manufacturing of living cell therapies. Cellular Intelligence is applying an AI foundation model to Novo Nordisk’s clinical-stage Parkinson’s program to speed development, reduce costs, and produce scalable, personalized treatments, with potential applications to cancer and other diseases.